Heroin use is skyrocketing across the US for several reasons. As states crack down on pill mills and prescription painkillers become less available and more expensive, many people addicted to opioids like OxyContin are turning to heroin, which is cheaper to obtain illegally. Additionally, pharmaceutical companies making prescription pain pills harder to abuse has led some users to switch to heroin. While painkiller abuse still exceeds heroin use, the rate of new heroin users has increased sharply in recent years. Experts argue that increased funding for treatment programs could help curb the rise in heroin addiction.
Opioid Addiction: New Approach Gives Hope to Patients Awaiting TreatmentSov Addiction Rehab
Dr. Stacey Sigmon and her colleagues at the University of Vermont have developed a new interim treatment for opioid addiction that can help patients awaiting comprehensive treatment. The interim treatment involves dispensing buprenorphine, a medication approved for opioid addiction treatment, through an electronic dispenser that provides a single daily dose. A 12-week trial showed this interim treatment helped waitlisted opioid dependent participants experience abstinence from illicit drug use while awaiting intensive care treatment.
We honor ourselves when we speak out for recovery. We show the world that recovery matters because it brings hope and peace into the lives of individuals and their loved ones. ~ Beth Wilson
The only person you are destined to become is the person you decide to be. ~ Ralph Waldo Emerson
Success is the sum of small efforts, repeated day in and day out.
~ Robert Collier
West Virginia has high rates of opioid and benzodiazepine prescription and misuse according to the document. It ranks third highest for opioid prescriptions per capita and first for benzodiazepine prescriptions. In 2014 over 400,000 opioid prescriptions and 300,000 benzodiazepine prescriptions were filled for West Virginia Medicaid recipients. West Virginia Medicaid has policies like quantity limits and a lock-in program to curb prescription drug abuse and encourages providers and recipients to follow best practices for responsible prescribing and use.
The document discusses the increasing abuse of heroin in the United States and its link to prescription drug abuse. It provides data from reports showing that people who abuse prescription painkillers are 19 times more likely to abuse heroin. With increased demand, drug trafficking organizations have increased heroin availability and purity. Law enforcement data demonstrates rising heroin seizures and overdose deaths linked to increased prescription opioid abuse. The document examines how some prescription opioid abusers may be turning to cheaper heroin as painkiller restrictions take effect.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
The document summarizes the opioid epidemic in the United States and the response from the Department of Health and Human Services (HHS). It provides data showing that prescription opioids are the most commonly abused drugs and that opioid overdose deaths have increased significantly since 1999. The HHS Secretary launched an Opioid Initiative in 2015 focused on improving opioid prescribing practices, increasing access to naloxone to reverse overdoses, and expanding medication-assisted treatment for opioid use disorders. Partnerships with health organizations aim to train providers and increase access to prevention and treatment services. States like Washington that implemented comprehensive approaches have seen declines in overdose deaths and hospitalizations.
Heroin use is skyrocketing across the US for several reasons. As states crack down on pill mills and prescription painkillers become less available and more expensive, many people addicted to opioids like OxyContin are turning to heroin, which is cheaper to obtain illegally. Additionally, pharmaceutical companies making prescription pain pills harder to abuse has led some users to switch to heroin. While painkiller abuse still exceeds heroin use, the rate of new heroin users has increased sharply in recent years. Experts argue that increased funding for treatment programs could help curb the rise in heroin addiction.
Opioid Addiction: New Approach Gives Hope to Patients Awaiting TreatmentSov Addiction Rehab
Dr. Stacey Sigmon and her colleagues at the University of Vermont have developed a new interim treatment for opioid addiction that can help patients awaiting comprehensive treatment. The interim treatment involves dispensing buprenorphine, a medication approved for opioid addiction treatment, through an electronic dispenser that provides a single daily dose. A 12-week trial showed this interim treatment helped waitlisted opioid dependent participants experience abstinence from illicit drug use while awaiting intensive care treatment.
We honor ourselves when we speak out for recovery. We show the world that recovery matters because it brings hope and peace into the lives of individuals and their loved ones. ~ Beth Wilson
The only person you are destined to become is the person you decide to be. ~ Ralph Waldo Emerson
Success is the sum of small efforts, repeated day in and day out.
~ Robert Collier
West Virginia has high rates of opioid and benzodiazepine prescription and misuse according to the document. It ranks third highest for opioid prescriptions per capita and first for benzodiazepine prescriptions. In 2014 over 400,000 opioid prescriptions and 300,000 benzodiazepine prescriptions were filled for West Virginia Medicaid recipients. West Virginia Medicaid has policies like quantity limits and a lock-in program to curb prescription drug abuse and encourages providers and recipients to follow best practices for responsible prescribing and use.
The document discusses the increasing abuse of heroin in the United States and its link to prescription drug abuse. It provides data from reports showing that people who abuse prescription painkillers are 19 times more likely to abuse heroin. With increased demand, drug trafficking organizations have increased heroin availability and purity. Law enforcement data demonstrates rising heroin seizures and overdose deaths linked to increased prescription opioid abuse. The document examines how some prescription opioid abusers may be turning to cheaper heroin as painkiller restrictions take effect.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
The document summarizes the opioid epidemic in the United States and the response from the Department of Health and Human Services (HHS). It provides data showing that prescription opioids are the most commonly abused drugs and that opioid overdose deaths have increased significantly since 1999. The HHS Secretary launched an Opioid Initiative in 2015 focused on improving opioid prescribing practices, increasing access to naloxone to reverse overdoses, and expanding medication-assisted treatment for opioid use disorders. Partnerships with health organizations aim to train providers and increase access to prevention and treatment services. States like Washington that implemented comprehensive approaches have seen declines in overdose deaths and hospitalizations.
This document summarizes opioid prescribing trends, policies, and their impacts in Canada and at the US-Canada border. It finds that while Canada and the US have high opioid consumption, Canadian policies like introducing tamper-deterrent OxyContin and a prescription monitoring program reduced potentially inappropriate prescribing by 1%. However, over 1 million such prescriptions remain, and inconsistencies in provincial policies and lack of prescriber access to prescription data limit the policies. The approval of generic long-acting oxycodone in Canada did not increase trafficking into the US, though losses cannot be tracked. Ongoing evaluation is needed to improve policies around opioid availability and curb misuse across the border.
Midwestern states have adopted various harm reduction strategies to address the opioid epidemic, including syringe exchange programs, medication-assisted treatment, overdose prevention, and prescription drug monitoring programs. Syringe exchanges provide sterile supplies to injection drug users to prevent disease spread, and are permitted in some form in most Midwestern states. All states except Kansas allow naloxone access to reverse overdoses. Several states mandate medication-assisted treatment coverage by Medicaid and most have implemented prescription drug monitoring programs, though requirements vary between states.
The document discusses efforts to address the opioid epidemic in the United States, including:
- Increasing registration and use of prescription drug monitoring programs (PDMPs) to track opioid prescriptions.
- Reducing the stigma around both pain and substance use disorder to increase access to comprehensive treatment.
- Expanding access to naloxone to prevent overdose deaths and "Good Samaritan" legal protections.
- Ongoing education of physicians on safe opioid prescribing and alternative pain management strategies.
The document discusses approaches to drug pricing and access in various countries. It provides details on Health Canada's proposal for expanded international reference pricing, including the criteria for selecting reference countries. The document also examines the impact of international reference pricing on product introduction delays and launch sequencing. It analyzes mechanisms for price setting and reimbursement across different countries. Finally, it touches on reservation prices in negotiations and Germany's multi-stage process for drug reimbursement decisions.
This document discusses strategies to curb prescription drug abuse, specifically opioid abuse, in West Virginia. It notes that West Virginia has the highest drug overdose mortality rate in the US and clinicians there write a high number of opioid prescriptions. It explores reasons for high prescribing rates and discusses solutions like improving education for patients and doctors, changing financial incentives, using prescription drug monitoring programs, and following CDC guidelines for safer opioid prescribing. Alternative therapies for pain management and the role of EDIE in monitoring patients and interfacing with PDMPs are also covered. The document advocates for internal referrals to pain specialists and multidisciplinary approaches to pain care.
The abuse of prescription painkillers and illicit opioids has become a public health concern in the United States of America. The Centers for Disease Control and Prevention (CDC) reports that more than 1,000 Americans are given treatment in emergency departments every day for misusing prescription opioids.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...Epstein Becker Green
Part of a "first Thursdays" fall webinar series hosted by Behavioral Health Association of Providers, Epstein Becker & Green, P.C., and Nelson Hardiman, LLP.
Presented by:
Francesca R. Ozinal – Associate, Epstein Becker Green
Andrew Martin – Chief Operating Officer, Behavioral Health Association of Providers
Despite reports identifying medication-assisted treatment (MAT) as a critical element of evidence-based treatment, confusion concerning who may dispense, associated compliance requirements, and the relationship between MAT provision and behavioral health providers continues to impede access to MAT.
This webinar will review key licensing and operational issues concerning the various types of MAT, including buprenorphine, naltrexone, and methadone, as well as misperceptions and key compliance issues in instituting MAT.
More info: https://www.ebglaw.com/events/mystified-by-mat-navigating-the-changing-regulatory-landscape-around-medication-assisted-treatment/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
1) Prescription drug abuse in the U.S. has reached epidemic levels, with overdose deaths, opioid sales, and treatment admissions all rising in parallel since 1999. 2) To reverse the epidemic, efforts are needed to improve prescription drug monitoring programs (PDMPs), ensure safer opioid prescribing practices, expand access to treatment including buprenorphine, and support state-level prevention strategies. 3) Early evidence suggests that real-time, universal PDMPs; mandating their use; integrating them into electronic health records; and comprehensive laws can all help to reduce doctor shopping, opioid prescribing, and overdose deaths.
This document summarizes a presentation on insights from state policies and interventions to curb prescription drug overdoses. It describes several interventions:
1) PRIMUM, a system in North Carolina that alerts prescribers to patients' risk of misusing or abusing opioids at the point of care.
2) A project in Rhode Island that developed protocols to improve opioid prescription safety for trauma patients, including alerts if prescriptions exceed dosage thresholds and requiring naloxone co-prescriptions.
3) A study in Pennsylvania that used Medicaid claims data to identify risk factors for opioid overdoses, such as high dosage and multiple prescribers/pharmacies, to target high-risk patients.
CMS recently announced a proposed rule for Medicaid (CMS-2482-P) that builds on current policies to help ensure that opioid prescribing is appropriate, medically necessary, and avoids adverse medical events.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Listeners participated in a live panel session addressing OHIP+, the recently announced expansion of the Ontario drug program to cover young people who are younger than 25 years-old.
CMS recently announced a proposed rule for Medicaid (CMS-2482-P) that builds on current policies to help ensure that opioid prescribing is appropriate, medically necessary, and avoids adverse medical events.
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxglendar3
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxtodd581
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
This document summarizes opioid prescribing trends, policies, and their impacts in Canada and at the US-Canada border. It finds that while Canada and the US have high opioid consumption, Canadian policies like introducing tamper-deterrent OxyContin and a prescription monitoring program reduced potentially inappropriate prescribing by 1%. However, over 1 million such prescriptions remain, and inconsistencies in provincial policies and lack of prescriber access to prescription data limit the policies. The approval of generic long-acting oxycodone in Canada did not increase trafficking into the US, though losses cannot be tracked. Ongoing evaluation is needed to improve policies around opioid availability and curb misuse across the border.
Midwestern states have adopted various harm reduction strategies to address the opioid epidemic, including syringe exchange programs, medication-assisted treatment, overdose prevention, and prescription drug monitoring programs. Syringe exchanges provide sterile supplies to injection drug users to prevent disease spread, and are permitted in some form in most Midwestern states. All states except Kansas allow naloxone access to reverse overdoses. Several states mandate medication-assisted treatment coverage by Medicaid and most have implemented prescription drug monitoring programs, though requirements vary between states.
The document discusses efforts to address the opioid epidemic in the United States, including:
- Increasing registration and use of prescription drug monitoring programs (PDMPs) to track opioid prescriptions.
- Reducing the stigma around both pain and substance use disorder to increase access to comprehensive treatment.
- Expanding access to naloxone to prevent overdose deaths and "Good Samaritan" legal protections.
- Ongoing education of physicians on safe opioid prescribing and alternative pain management strategies.
The document discusses approaches to drug pricing and access in various countries. It provides details on Health Canada's proposal for expanded international reference pricing, including the criteria for selecting reference countries. The document also examines the impact of international reference pricing on product introduction delays and launch sequencing. It analyzes mechanisms for price setting and reimbursement across different countries. Finally, it touches on reservation prices in negotiations and Germany's multi-stage process for drug reimbursement decisions.
This document discusses strategies to curb prescription drug abuse, specifically opioid abuse, in West Virginia. It notes that West Virginia has the highest drug overdose mortality rate in the US and clinicians there write a high number of opioid prescriptions. It explores reasons for high prescribing rates and discusses solutions like improving education for patients and doctors, changing financial incentives, using prescription drug monitoring programs, and following CDC guidelines for safer opioid prescribing. Alternative therapies for pain management and the role of EDIE in monitoring patients and interfacing with PDMPs are also covered. The document advocates for internal referrals to pain specialists and multidisciplinary approaches to pain care.
The abuse of prescription painkillers and illicit opioids has become a public health concern in the United States of America. The Centers for Disease Control and Prevention (CDC) reports that more than 1,000 Americans are given treatment in emergency departments every day for misusing prescription opioids.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...Epstein Becker Green
Part of a "first Thursdays" fall webinar series hosted by Behavioral Health Association of Providers, Epstein Becker & Green, P.C., and Nelson Hardiman, LLP.
Presented by:
Francesca R. Ozinal – Associate, Epstein Becker Green
Andrew Martin – Chief Operating Officer, Behavioral Health Association of Providers
Despite reports identifying medication-assisted treatment (MAT) as a critical element of evidence-based treatment, confusion concerning who may dispense, associated compliance requirements, and the relationship between MAT provision and behavioral health providers continues to impede access to MAT.
This webinar will review key licensing and operational issues concerning the various types of MAT, including buprenorphine, naltrexone, and methadone, as well as misperceptions and key compliance issues in instituting MAT.
More info: https://www.ebglaw.com/events/mystified-by-mat-navigating-the-changing-regulatory-landscape-around-medication-assisted-treatment/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
1) Prescription drug abuse in the U.S. has reached epidemic levels, with overdose deaths, opioid sales, and treatment admissions all rising in parallel since 1999. 2) To reverse the epidemic, efforts are needed to improve prescription drug monitoring programs (PDMPs), ensure safer opioid prescribing practices, expand access to treatment including buprenorphine, and support state-level prevention strategies. 3) Early evidence suggests that real-time, universal PDMPs; mandating their use; integrating them into electronic health records; and comprehensive laws can all help to reduce doctor shopping, opioid prescribing, and overdose deaths.
This document summarizes a presentation on insights from state policies and interventions to curb prescription drug overdoses. It describes several interventions:
1) PRIMUM, a system in North Carolina that alerts prescribers to patients' risk of misusing or abusing opioids at the point of care.
2) A project in Rhode Island that developed protocols to improve opioid prescription safety for trauma patients, including alerts if prescriptions exceed dosage thresholds and requiring naloxone co-prescriptions.
3) A study in Pennsylvania that used Medicaid claims data to identify risk factors for opioid overdoses, such as high dosage and multiple prescribers/pharmacies, to target high-risk patients.
CMS recently announced a proposed rule for Medicaid (CMS-2482-P) that builds on current policies to help ensure that opioid prescribing is appropriate, medically necessary, and avoids adverse medical events.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Listeners participated in a live panel session addressing OHIP+, the recently announced expansion of the Ontario drug program to cover young people who are younger than 25 years-old.
CMS recently announced a proposed rule for Medicaid (CMS-2482-P) that builds on current policies to help ensure that opioid prescribing is appropriate, medically necessary, and avoids adverse medical events.
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxglendar3
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxtodd581
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
Seeking medical attention for chronic pain is often the primary reason behind prescribing opioids. The practice of prescribing opioid painkillers has been so rampant that it led to an epidemic, which the United States has been struggling with for decades. Although medical practices, guidelines and recommendations explicitly point out that prescribing opioid pain pills should always outweigh the risks, they continue to wreak havoc across the North American continent.
The Centers for Medicare & Medicaid Services outlines their opioid misuse strategy to address the national opioid epidemic. Their strategy includes 4 priority areas: 1) implementing more effective strategies to reduce risks of opioid use disorder, overdoses, and inappropriate prescribing; 2) expanding access to naloxone to reverse overdoses; 3) expanding screening, diagnosis, and treatment of opioid use disorder including medication-assisted treatment; and 4) increasing use of evidence-based practices for pain management. Opioid misuse has led to alarming increases in overdoses and deaths, and CMS aims to combat this through promoting safe opioid use, improving access to treatment, and alternative pain management options.
The document discusses harm reduction strategies for drug policy. It summarizes the mission of Law Enforcement Against Prohibition (LEAP) to educate about the failure of the war on drugs and reduce harms. It also discusses overdose prevention, drug treatment courts, safe injection sites, and decriminalization efforts in places like Vancouver and the Netherlands that aim to improve public health and safety.
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™
This document summarizes the growing problem of prescription drug abuse in America. Key points include:
- Prescription drug abuse is now the nation's fastest growing drug problem, with opioids like oxycodone being abused at increasing rates.
- Education of healthcare providers, patients, and the public is needed to increase awareness of the dangers of prescription drug misuse and how to properly use and dispose of medications.
- Tracking programs like prescription drug monitoring programs (PDMPs) in states can help identify "doctor shoppers" and reduce diversion, though more research is still needed on their effectiveness.
- A multifaceted approach including education, monitoring, safe disposal, and enforcement is needed to address the crisis of prescription drug
The document discusses the growing heroin addiction epidemic in the United States. It notes that prescription opioid misuse has led many Americans to turn to heroin and that overdose deaths have more than tripled since 2010. It provides information on prevention and treatment efforts, including expanding access to the overdose reversal drug naloxone and increasing medically-assisted treatment programs. The document also discusses Walgreens' efforts to install safe drug disposal kiosks and make naloxone available without a prescription to help address the crisis.
This is the latest in both national, Virginia and Chesterfield County heroin task force updates. Includes the latest HARP statistics. File created by Valerie Murphy at SAFE, a nonprofit in Chesterfield County VA
ER visits for opioid overdoses is rising in the U.S. Accurate ER reports from medical transcription services and proactive action can help minimize risks.
Antonio Boone of the Office of HIV Planning reviewed major points from the Mayor's Task Force to Combat the Opioid Epidemic in Philadelphia at the June 12, 2017 Positive Committee meeting.
Massachusetts is facing an opioid epidemic that is a major public health threat. The state's 1999 health curriculum framework needs reforms to address the crisis, including placing limits on opioid prescriptions and developing treatment protocols for opioid addicts. The memorandum recommends adding a substance abuse screening test for high schools and colleges to help identify at-risk students and curb substance abuse among youth.
The director of the CDC discussed the prescription drug and opioid overdose epidemic in the United States. He noted that over 145,000 lives have been lost to prescription opioid overdoses in the past decade as opioid prescribing has increased 4-fold since 1999. The CDC is working with multiple states experiencing outbreaks of HIV linked to injection drug use. The director outlined a potential "technical package" of interventions including improving prescribing practices, increasing access to treatment, reducing drug availability, and public awareness campaigns. Progress requires a comprehensive, evidence-based public health approach with law enforcement and community involvement.
Four Effective Opioid Interventions for Healthcare LeadersHealth Catalyst
The crisis of opioid abuse in the U.S. is well known. What may not be so well known are the ways for clinicians and healthcare systems to minimize misuse of these addictive drugs. This article describes the risks for patients when they are prescribed opioids and the need for opioid intervention. It offers four approaches that healthcare systems can take to tackle the crisis while still relieving pain and suffering for the patients they serve:
Use data and analytics to inform strategies that reduce opioid availability
Adopt prescription drug monitoring programs to prevent misuse
Adopt evidence-based guidelines
Consider promising state strategies for dealing with prescription opioid overdose
Opioid misuse is a public health epidemic, but treatments are available and it’s time for those involved in the delivery of healthcare to change practices.
MedTech Healthcare Group is the largest provider of outpatient substance abuse treatment programs in Westmoreland and Indiana counties in Pennsylvania, operating three clinics over the past decade. It has treated thousands of patients for opioid addiction and helped reduce the impact of the opioid epidemic. MedTech is on track to generate $3 million in revenue and $900,000-1 million in EBITDA in 2015, with steady growth since its founding in 2006. The behavioral healthcare industry, particularly medication-assisted treatment (MAT) for opioid addiction, represents a large and growing market opportunity.
The document discusses the opioid crisis in the United States, including the increased prescribing and use of opioids for chronic pain management over the past 20 years. This has led to higher rates of addiction, overdose deaths, and a resurgence of heroin use. The document argues that more effective approaches are needed beyond just administering naloxone to reverse overdoses. It advocates adopting aspects of the physician health program model, which provides long-term treatment, monitoring, and support, and has shown success rates of 80% for physicians with substance use disorders after 5 years. The document concludes more structured support programs are needed for non-healthcare professionals recovering from opioid addiction and overdose.
Northern Nevada HOPES provides integrated medical and support services for marginalized populations, including those experiencing homelessness, drug users, sex workers, and people living in poverty. They use a harm reduction model to provide affordable and accessible healthcare. The document discusses Northern Nevada HOPES' mission and goals of improving community health. It also outlines facts about rising drug overdose rates in Nevada and argues for legislation allowing third parties like pharmacists to prescribe and dispense the opioid overdose reversal drug naloxone. The goals are to pass this naloxone legislation and increase knowledge of harm reduction strategies through community outreach.
Cannabiseutical(s) Inc. is a for-profit medical marijuana company established in Oregon in 2001 that plans to open integrated medical marijuana dispensaries and clinics. The dispensaries will utilize a model combining marijuana sales with services from practitioners like naturopaths and chiropractors. The company aims to tailor treatment plans to individual patients' needs using different cannabis strains tailored to specific ailments. Cannabiseutical(s) also plans research projects through a partnership with a Colorado nonprofit and to operate dispensaries like pharmacies with assigned prescription numbers.
Intro to Prevention: Psychopharmacology Guest LectureJulie Hynes
Current A&D Conditions in lane County: And why we need prevention. Guest lecturer: Julie Hynes, MA, RD, CPS - PreventionLane at Lane County Public Health
Northern Nevada HOPES provides integrated medical and support services for marginalized populations. They use a harm reduction model to provide affordable and accessible healthcare. Their mission is to build a healthier community through coordinated healthcare, medical services, behavioral health, and prevention services. The document discusses the opioid overdose epidemic and how legislation expanding access to the opioid overdose reversal drug naloxone could help reduce overdose deaths. It proposes goals of passing naloxone legislation and increasing harm reduction outreach efforts.
Methadone maintenance treatment (MMT) is an effective treatment for opioid dependence that reduces drug use and criminal behavior while improving physical and mental health. MMT involves replacing opioids with the long-acting opioid methadone, which prevents withdrawal symptoms and drug cravings without causing intoxication. MMT is most effective when combined with counseling and other social support services. While MMT is also used to treat adolescents, their treatment may differ due to incomplete brain development and greater risks. Comprehensive, individualized treatment addressing an adolescent's medical, psychological and social needs is important.
Similar to Canada's Response to the Opioid crisis | Jenn Galandy (20)
Why Can’t a Woman be Defence Minister for a Change? | Jenn Galandy Jenn Galandy, MA
Jenn Galandy was recently featured on Apolitical, a global learning platform for government. Here she writes an opinion article on the lack of female ministers and political leaders in government. To learn more about Jenn Galandy visit JennGalandy.com
Female Politicians and Activists Who Are Changing Britain| Jenn Galandy Jenn Galandy, MA
Jenn Galandy describes a few politicians and activist who are changing Britain for the better. To find out more about Jenn Galandy, visit JennGalandy.com or JennGalandy.org
Improving Gender Representation in Canadian Federal Politics and Parliament |...Jenn Galandy, MA
In spring of 2019, Jenn Galandy was published in the Canadian Parliamentary Review with her article focusing on the how gender representation can be improved within Canadian federal politics.
MPs Advocate For More Relaxed E-cigarette Rules | Jenn Galandy Jenn Galandy, MA
MPs in the UK are advocating for more relaxed rules regarding e-cigarettes. They argue that vaping is less harmful than smoking normal cigarettes and can help people quit smoking. The report calls for more freedom in e-cigarette advertising, relaxed regulations and taxes on e-cigarettes, and annual reviews of the health effects of vaping. It also discusses allowing vaping in public places like public transport. The responses to the report were mixed, with health groups wary of marketing to youth but supportive of helping smokers quit, while the public expressed concerns about unknown health risks of vaping in public.
What is Public Policy and How Does it Affect me? | Jenn Galandy Jenn Galandy, MA
Public policy refers to government policies that affect the whole population and are created in response to issues in a community. Politicians, bureaucrats, media, interest groups, and voters all play roles in the policymaking process through different tactics to influence policy. The average person can also influence policy through voting or getting involved in policy discussions. Public policy directly affects individuals through its impact on daily life, hobbies, and communities. For example, health policy in Alberta determines healthcare funding through taxes and provides free access to services, engaging citizens to evaluate spending and quality of services.
projet de traité négocié à Istanbul (anglais).pdfEdouardHusson
Ceci est le projet de traité qui avait été négocié entre Russes et Ukrainiens à Istanbul en mars 2022, avant que les Etats-Unis et la Grande-Bretagne ne détournent Kiev de signer.
16062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
13062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
केरल उच्च न्यायालय ने 11 जून, 2024 को मंडला पूजा में भाग लेने की अनुमति मांगने वाली 10 वर्षीय लड़की की रिट याचिका को खारिज कर दिया, जिसमें सर्वोच्च न्यायालय की एक बड़ी पीठ के समक्ष इस मुद्दे की लंबित प्रकृति पर जोर दिया गया। यह आदेश न्यायमूर्ति अनिल के. नरेंद्रन और न्यायमूर्ति हरिशंकर वी. मेनन की खंडपीठ द्वारा पारित किया गया
Recent years have seen a disturbing rise in violence, discrimination, and intolerance against Christian communities in various Islamic countries. This multifaceted challenge, deeply rooted in historical, social, and political animosities, demands urgent attention. Despite the escalating persecution, substantial support from the Western world remains lacking.
Federal Authorities Urge Vigilance Amid Bird Flu Outbreak | The Lifesciences ...The Lifesciences Magazine
Federal authorities have advised the public to remain vigilant but calm in response to the ongoing bird flu outbreak of highly pathogenic avian influenza, commonly known as bird flu.
#WenguiGuo#WashingtonFarm Guo Wengui Wolf son ambition exposed to open a far...rittaajmal71
Since fleeing to the United States in 2014, Guo Wengui has founded a number of projects in the United States, such as GTV Media Group, GTV private equity, farm loan project, G Club Operations Co., LTD., and Himalaya Exchange.
Youngest c m in India- Pema Khandu BiographyVoterMood
Pema Khandu, born on August 21, 1979, is an Indian politician and the Chief Minister of Arunachal Pradesh. He is the son of former Chief Minister of Arunachal Pradesh, Dorjee Khandu. Pema Khandu assumed office as the Chief Minister in July 2016, making him one of the youngest Chief Ministers in India at that time.
लालू यादव की जीवनी LALU PRASAD YADAV BIOGRAPHYVoterMood
Discover the life and times of Lalu Prasad Yadav with a comprehensive biography in Hindi. Learn about his early days, rise in politics, controversies, and contribution.
Slide deck with charts from our Digital News Report 2024, the most comprehensive exploration of news consumption habits around the world, based on survey data from more than 95,000 respondents across 47 countries.
15062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
12062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
ग्रेटर मुंबई के नगर आयुक्त को एक खुले पत्र में याचिका दायर कर 540 से अधिक मुंबईकरों ने सभी अवैध और अस्थिर होर्डिंग्स, साइनबोर्ड और इलेक्ट्रिक साइनेज को तत्काल हटाने और 13 मई, 2024 की शाम को घाटकोपर में अवैध होर्डिंग के गिरने की विनाशकारी घटना के बाद अपराधियों के खिलाफ सख्त कार्रवाई की मांग की है, जिसमें 17 लोगों की जान चली गई और कई निर्दोष लोग गंभीर रूप से घायल हो गए।
2. OPIOID OVERDOSE CRISIS
Canada is currently in the midst of an opioid overdose
crisis. The Public Health Agency of Canada revealed that in
2017, almost 3,000 people lost their lives in opioid-related
deaths. That is averaging to about eight deaths a day. The
opioid crisis has been linked to the rise of overdoses in
both prescription opioids and fentanyl. 72% of these deaths
are due to fentanyl, a drug that is described to be even
stronger than morphine. Due to the crisis, the Minister of
Health has made addressing this issue a top priority and
with the help of the government. Since the issue was
brought to concern in 2016, several policy changes have
been implemented as a response.
3. FEDERAL ACTION
To address the opioid crisis, the Health Portfolio aims to reform
the approach to drug policy making it more collaborative,
compassionate, comprehensive, and evidence-based. Based on the
values of the Health Portfolio, the Minister of Health has created a
new Canadian drugs and substances strategy. This strategy focuses
on a new approach to drug policy that focuses on a strong
foundation in the evidence, the restoration of harm reduction,
prevention, treatment, and enforcement. By responding to the
crisis through prevention, treatment, harm reduction, and
enforcement, the government of Canada is devoted to targeting
this public health emergency. The following are a few of the
actions that followed the change of drug policy.
4. GOOD SAMARITAN
DRUG OVERDOSE ACT
The Good Samaritan Drug
Overdose Act offers some
legal protection for those
who call for help in the case
of an emergency overdose.
Individuals are protected
from charges related to
possession of controlled
substance as well as
breaching conditions set by
parole, probation, etc. The act
was put in place in the hopes
that it will reduce the fear of
police arriving at an
overdoses scene and help to
influence others to step up
and save a life.
5. SUPERVISED
CONSUMPTION SITES
SCS offers a safe and
clean place to consume
illegal substances, access
to emergency medical
care, testing for infectious
diseases, access to sterile
drug equipment and
proper disposal. The
primary goals of SCS are
to help prevent overdose
death, reduce the
transmissions of diseases,
and help to make a
smoother transition to
drug treatment services
6. MAKING NALOXONE
FREELY AVAILABLE
Naloxone is a fast acting
drug that can reverse an
opioid overdose. This
allows time to get
overdose victims time to
get to the hospital before
it is too late. Across the
provinces and territories
of Canada, people can
receive Naloxone at
pharmacies without the
need of any prescription.
Some pharmacies are
even offering free
Naloxone kits.
7. CONCLUSION
Although Canada’s opioid crisis is far from being over, the
government has taken initiatives in helping to decrease the death
toll. This crisis is an incredibly complex health and social issue
that will require time to see change.